Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823914 · ClinicalTrials.gov registry record
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 116
- Enrollment target
NCT00823914: Completed study, sponsored by Massachusetts General Hospital.
NCT00823914 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00823914 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
Objective of the study is to create and validate Chronic Quality of Life (CQOL) index that explores habits, career paths and other life choices psoriasis patients make as a result of coping with their disease that may not be impacted by therapy implemented at a given point in time. \- The investigators think this data will show that patients who were diagnosed at a young age will have worse chronic quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-12 |
What the finished NCT00823914 record still lists
NCT00823914 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00823914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00823914 about?
NCT00823914 is a clinical study titled "Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life". Objective of the study is to create and validate Chronic Quality of Life (CQOL) index that explores habits, career paths and other life choices psoriasis patients make as a result of coping with their disease that may not be impacted by therapy implemented at a given point in time. \- The investiga...
What is the current status of trial NCT00823914?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2008-12. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00823914?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia